Skip to main content

Kazano (metformin hydrochloride/alogliptin benzoate) Shopper Approved

Prescription Prescription Required FormationFormulation: Tablet

Kazano

(Brand Option)

Select the prescribed dosage

Select the quantity to see the price.

  *  
Prescription Prescription Required FormationFormulation: Tablet

metformin hydrochloride/alogliptin benzoate

We don't sell this generic-version medication.

Select the quantity to see the price.

  *  
delivery

* This price includes a dispensing fee, medical review fee, and packing fee.

delivery

Shipped and delivered directly to your doorstep

Kazano (alogliptin and metformin hydrochloride) is a prescription medication used to help control blood sugar levels in adults with type 2 diabetes mellitus.

Type 2 diabetes is a chronic condition that develops when the body does not use insulin effectively or cannot produce enough insulin to maintain healthy blood sugar levels.

Insulin is a hormone produced by the pancreas that helps glucose (sugar) move from the bloodstream into the body’s cells, where it is used for energy.

When insulin does not work properly, glucose remains in the bloodstream, causing blood sugar levels to rise.

Over time, uncontrolled blood sugar can damage blood vessels, nerves, kidneys, and other organs.

Kazano contains two active ingredients that work together to improve blood sugar control:

  • Alogliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin release and reduce excess glucose production after meals.
  • Metformin Hydrochloride: A biguanide that reduces glucose production in the liver and helps the body respond more effectively to insulin.

By combining these two medications, Kazano helps lower elevated blood sugar levels through complementary mechanisms.

Kazano is intended to be used alongside a balanced diet and regular physical activity to improve glycemic control in adults with type 2 diabetes.

Glycemic control refers to keeping blood sugar levels within a recommended range.

Kazano is not intended to treat type 1 diabetes or diabetic ketoacidosis.

Your healthcare provider will determine whether Kazano is appropriate based on your blood sugar levels, kidney function, medical history, and response to previous diabetes medications.

Treatment of Type 2 Diabetes Mellitus

Kazano is indicated for improving blood sugar control in adults with type 2 diabetes mellitus.

Type 2 diabetes occurs when the body becomes resistant to insulin or the pancreas cannot produce enough insulin to meet the body’s needs.

Insulin resistance means that the body’s cells do not respond properly to insulin.

As a result, glucose has difficulty entering muscle, fat, and other cells.

The liver may also release too much glucose into the bloodstream, contributing to elevated blood sugar levels.

Common symptoms of type 2 diabetes include:

  • Frequent Urination: The body attempts to remove excess glucose through urine.
  • Increased Thirst: Fluid loss caused by frequent urination may lead to dehydration.
  • Persistent Fatigue: Cells may not receive or use glucose efficiently for energy.
  • Blurred Vision: Elevated blood sugar can temporarily affect the eye’s focusing ability.
  • Increased Hunger: Changes in glucose regulation may affect appetite.
  • Slow Wound Healing: High blood sugar can interfere with normal tissue repair.
  • Frequent Infections: Elevated glucose levels may increase susceptibility to certain infections.
  • Tingling or Numbness: Long-term high blood sugar may damage peripheral nerves.

Some people with type 2 diabetes have no noticeable symptoms, especially during the early stages.

For this reason, regular blood sugar testing is important for identifying and managing the condition.

Kazano helps improve blood sugar control by targeting two important processes involved in type 2 diabetes: insulin regulation and glucose production in the liver.

The alogliptin component helps the pancreas release more insulin when blood sugar levels are elevated. It also reduces the release of glucagon, a hormone that signals the liver to produce glucose.

The metformin component reduces glucose production in the liver and improves the body’s response to insulin.

Together, these actions help lower fasting and after-meal blood sugar levels.

Benefits of Kazano for Type 2 Diabetes

Kazano combines two diabetes medications in a single tablet, allowing them to work together to improve glucose regulation.

Potential benefits include:

  • Improved Blood Sugar Control: Helps reduce elevated blood sugar levels in adults with type 2 diabetes.
  • Lower Fasting Blood Sugar: Metformin reduces excess glucose production by the liver.
  • Better After-Meal Glucose Control: Alogliptin helps regulate insulin and glucagon activity after eating.
  • Improved Insulin Sensitivity: Metformin helps the body’s cells respond more effectively to insulin.
  • Reduced HbA1c Levels: Treatment may lower glycated hemoglobin (HbA1c), a measure of average blood sugar over approximately two to three months.
  • Convenient Combination Therapy: Provides two complementary medications in one tablet.

Kazano is generally used when treatment with both alogliptin and metformin is appropriate.

It may be prescribed when blood sugar is not adequately controlled with metformin alone or when a healthcare provider determines that combination therapy is needed.

However, Kazano does not permanently cure type 2 diabetes.

Patients should continue following their recommended meal plan, physical activity routine, and blood sugar monitoring schedule.

How Does Kazano Work?

Kazano contains two active ingredients, alogliptin and metformin hydrochloride, that work together to lower blood sugar levels in adults with type 2 diabetes.

Each ingredient targets a different process involved in glucose regulation.

Alogliptin: Increases Incretin Hormone Activity

Alogliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors.

DPP-4 is an enzyme that breaks down incretin hormones, which are released by the intestines after eating.

Two important incretin hormones are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

These hormones help regulate blood sugar by encouraging the pancreas to release insulin when glucose levels are elevated.

Alogliptin blocks the DPP-4 enzyme, allowing incretin hormones to remain active for longer.

This helps improve glucose regulation through two actions:

  • Increases Insulin Release: Encourages the pancreas to release insulin when blood sugar levels are high.
  • Reduces Glucagon Secretion: Helps reduce excess glucose production by the liver.

Because its effects depend partly on blood sugar levels, alogliptin generally has a low risk of causing hypoglycemia when used without insulin or certain other diabetes medications.

Metformin: Reduces Glucose Production and Improves Insulin Sensitivity

Metformin belongs to a class of medications called biguanides.

Its primary action is to reduce the amount of glucose produced and released by the liver.

The liver normally releases glucose into the bloodstream to provide energy between meals and during fasting.

However, in people with type 2 diabetes, the liver may release more glucose than the body needs.

Metformin helps reduce this excess glucose production.

It also improves insulin sensitivity, allowing muscle and other body cells to respond more effectively to insulin.

This helps the body use circulating glucose more efficiently.

Unlike medications that directly stimulate insulin release, metformin does not usually cause low blood sugar when taken alone.

Combined Effects on Blood Sugar Control

Alogliptin and metformin work together through complementary mechanisms.

Alogliptin supports the body’s natural insulin response after meals, while metformin reduces excess glucose production in the liver and improves insulin sensitivity.

Together, these actions help lower blood sugar levels throughout the day.

Kazano may also reduce HbA1c levels, helping healthcare providers assess longer-term glucose control.

How Long Does Kazano Take to Work?

Kazano begins affecting blood sugar regulation after treatment starts, although the time needed to notice improvements varies between individuals.

Some people may see changes in their blood sugar readings within the first several days or weeks.

However, the full effect on HbA1c is usually assessed after approximately three months because this test reflects average blood sugar levels over the previous two to three months.

Kazano is generally taken twice daily with food. Taking it with meals helps reduce gastrointestinal side effects associated with metformin, such as nausea, diarrhea, and abdominal discomfort.

Your healthcare provider will monitor your blood sugar levels and kidney function to evaluate treatment effectiveness and safety.

Important Information About Kazano

Kazano is not suitable for everyone. Kidney function must be assessed before treatment because reduced kidney function can increase the risk of medication-related complications.

Metformin may rarely cause lactic acidosis, a serious condition involving excessive acid buildup in the bloodstream. Alogliptin has also been associated with serious adverse reactions, including pancreatitis and heart failure concerns in susceptible individuals.

Tell your healthcare provider if you have kidney disease, liver problems, heart failure, or a history of pancreatitis before taking Kazano.

Kazano helps control type 2 diabetes by combining two medications that regulate blood sugar through different mechanisms. When used alongside diet and exercise, it can improve glucose control and help reduce the risk of complications associated with prolonged high blood sugar.

Kazano is a prescription medication used to help control blood sugar levels in adults with type 2 diabetes mellitus.

Kazano contains two active ingredients that work together to improve blood sugar control. Alogliptin helps the body release insulin when blood sugar levels are high, while metformin reduces glucose production in the liver and improves insulin sensitivity.

Kazano is available as an oral tablet and is usually taken twice daily with meals. Taking the medication with food helps reduce stomach-related side effects, including nausea, diarrhea, and abdominal discomfort.

Your healthcare provider will determine the appropriate dosage based on your blood sugar levels, kidney function, response to treatment, and other medications you take.

How to Take Kazano Tablets

Follow these steps to take Kazano correctly and safely:

  1. Follow Your Prescribed Dosage: Take Kazano exactly as directed by your healthcare provider. Do not increase or decrease your dosage without medical advice.
  2. Take Kazano Twice Daily: The medication is generally taken once in the morning and once in the evening, unless your healthcare provider recommends a different schedule.
  3. Take With Meals: Take Kazano with food to help reduce gastrointestinal side effects associated with metformin.
  4. Swallow the Tablet Whole: Take the tablet with a glass of water. Do not split, crush, or chew Kazano tablets.
  5. Drink Enough Fluids: Maintain adequate hydration throughout the day unless your healthcare provider has recommended limiting your fluid intake.
  6. Take It at Consistent Times: Try to take Kazano at approximately the same times every day to maintain a regular treatment routine.
  7. Follow Your Diabetes Management Plan: Continue following your recommended diet, physical activity routine, and other prescribed diabetes treatments.
  8. Monitor Your Blood Sugar: Check your blood glucose levels as recommended by your healthcare provider.
  9. Record Your Results: Keep track of your blood sugar readings and share them with your healthcare provider during follow-up appointments.
  10. Report Unusual Symptoms: Contact your healthcare provider if you experience persistent stomach discomfort, frequent low blood sugar readings, or other unexpected symptoms.

If you have difficulty swallowing Kazano tablets whole, talk to your healthcare provider or pharmacist about your treatment options.

Recommended Dosage of Kazano

The recommended dosage of Kazano depends on your current diabetes treatment, kidney function, and individual response.

Kazano is available in the following tablet strengths:

Tablet strength Alogliptin Metformin hydrochloride
12.5 mg/500 mg 12.5 mg 500 mg
12.5 mg/1000 mg 12.5 mg 1000 mg

For adults with normal kidney function, the recommended maximum daily dosage is generally 25 mg of alogliptin and 2000 mg of metformin, divided into two doses.

Your healthcare provider may recommend starting with a lower dose of metformin to reduce gastrointestinal discomfort.

The starting dosage may also depend on whether you are already taking metformin or alogliptin separately.

Kazano is not suitable for people with certain levels of kidney impairment. Your healthcare provider will assess your kidney function before prescribing the medication.

Do not change your prescribed dosage or switch between tablet strengths without medical advice.

Why Should Kazano Be Taken With Food?

Kazano should be taken with meals because its metformin component may cause digestive side effects, especially when treatment begins.

Metformin can affect the digestive system and may cause nausea, diarrhea, abdominal discomfort, or an upset stomach.

Taking Kazano with food helps reduce these symptoms and may make the medication easier to tolerate.

For example, if you are prescribed Kazano twice daily, your healthcare provider may recommend taking one tablet with breakfast and another with your evening meal.

Try to take the medication with meals at approximately the same times each day.

If you continue to experience stomach discomfort, contact your healthcare provider. Your dosage or treatment plan may need adjustment.

Why Is Regular Dosing Important?

Taking Kazano consistently helps maintain its blood sugar-lowering effects.

Type 2 diabetes is a chronic condition that often requires ongoing treatment to keep blood glucose levels within a recommended range.

Kazano helps manage blood sugar through two complementary actions.

Alogliptin increases the activity of incretin hormones, helping regulate insulin and glucagon levels after meals.

Metformin reduces excess glucose production by the liver and helps the body’s cells respond more effectively to insulin.

Together, these effects help control fasting and after-meal blood sugar levels.

If you miss doses frequently or change your medication schedule, your blood sugar levels may become harder to control.

Continue taking Kazano even if you feel well, unless your healthcare provider instructs you to stop.

How Should I Monitor My Blood Sugar While Taking Kazano?

Regular blood sugar monitoring helps determine how well Kazano is controlling your type 2 diabetes.

Your healthcare provider will explain how often you should check your glucose levels based on your medications, treatment goals, and overall health.

Some people use a blood glucose meter, while others may use a continuous glucose monitoring (CGM) system.

Your healthcare provider may recommend checking blood sugar at specific times, such as before meals, after meals, or when symptoms occur.

Keep a record of your readings, particularly if your blood sugar levels are frequently above or below your recommended range.

Your healthcare provider may also order an HbA1c test, which measures your average blood sugar levels over approximately two to three months.

If your blood sugar remains consistently high or low, your healthcare provider may recommend adjustments to your medication, diet, or physical activity routine.

Do not increase or decrease your Kazano dosage based on a single blood sugar reading unless you have been given specific instructions.

What Should I Do If My Blood Sugar Is Too High or Too Low?

High blood sugar, also called hyperglycemia, occurs when glucose levels rise above your recommended range.

Possible symptoms include increased thirst, frequent urination, fatigue, and blurred vision.

If you regularly experience high blood sugar readings, contact your healthcare provider. Your diabetes management plan may need adjustment.

Low blood sugar, also called hypoglycemia, occurs when glucose levels become too low.

Kazano generally has a low risk of causing hypoglycemia when taken alone. However, the risk may increase when it is combined with insulin or sulfonylurea medications.

Possible symptoms include:

  • Shakiness: Trembling or feeling unusually weak.
  • Sweating: Sudden sweating without physical activity.
  • Hunger: Feeling extremely hungry.
  • Dizziness: Lightheadedness or difficulty maintaining balance.
  • Rapid Heartbeat: Feeling that your heart is racing.
  • Confusion: Difficulty concentrating or thinking clearly.

If your blood sugar is below 70 mg/dL (3.9 mmol/L) and you are awake and able to swallow, follow your healthcare provider’s hypoglycemia treatment instructions. A common approach is to consume 15 grams of fast-acting carbohydrates, recheck your blood sugar after 15 minutes, and repeat if it remains low.

Severe hypoglycemia involving unconsciousness, seizures, or an inability to swallow requires emergency medical assistance.

What Should I Do If I Miss a Dose of Kazano?

If you forget to take Kazano, take the missed dose when you remember, preferably with food.

However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.

Do not take two doses together to make up for a missed dose.

Taking extra Kazano may increase the risk of side effects, including digestive problems and potentially serious complications related to metformin.

If you frequently miss doses, consider using medication reminders or establishing a consistent daily routine.

Contact your healthcare provider or pharmacist if you are unsure how to manage a missed dose.

Important Precautions When Taking Kazano

Kazano contains metformin, which can rarely cause a serious condition called lactic acidosis.

Lactic acidosis occurs when too much lactic acid builds up in the bloodstream.

The risk is higher in people with significant kidney impairment, severe dehydration, certain serious illnesses, or conditions that reduce oxygen delivery to body tissues.

Seek immediate medical attention if you develop severe weakness, unusual muscle pain, breathing difficulties, persistent abdominal discomfort, or unusual drowsiness.

Your healthcare provider may recommend temporarily stopping Kazano during certain illnesses involving vomiting, diarrhea, or dehydration, or before specific procedures involving iodinated contrast dye.

Do not stop or restart treatment without following your healthcare provider’s instructions.

When to Contact Your Healthcare Provider

Contact your healthcare provider if you experience persistent nausea, diarrhea, abdominal discomfort, unusually high or low blood sugar readings, or other symptoms affecting your daily activities.

Tell your healthcare provider about all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you take.

Your healthcare provider will monitor your blood sugar levels, kidney function, and overall response to treatment.

Seek emergency medical attention if you experience severe breathing difficulties, confusion, loss of consciousness, or symptoms suggesting lactic acidosis.

Kazano helps manage type 2 diabetes when taken regularly with meals and combined with appropriate diet and physical activity. Following your prescribed dosage, monitoring blood sugar levels, and attending regular medical appointments can help maintain effective glucose control and reduce the risk of complications.

Common Side Effects of Kazano (Metformin Hydrochloride/Alogliptin benzoate):

Serious Side Effects of Kazano (Metformin Hydrochloride/Alogliptin benzoate):

  • Dark urine
  • Feeling cold
  • Feeling dizzy
  • Light-headed
  • Loss of appetite
  • Pain or burning when you urinate
  • Severe or ongoing pain in your joints
  • Shortness of breath (even while lying down)
  • Slow or irregular heart rate
  • Stomach pain
  • Swelling in your legs or feet, rapid weight gain
  • Tiredness
  • Trouble breathing
  • Unusual muscle pain
  • Upper stomach pain
  • Yellowing of the skin or eyes (jaundice)

Kazano (metformin hydrochloride/alogliptin benzoate) is available in the following forms and strength:

Kazano: Tablet

  • 12.5 mg/1000 mg

Before taking Kazano, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.

Kazano is a prescription medication used to improve blood sugar control in adults with type 2 diabetes mellitus. It combines two active ingredients that work together to lower elevated blood sugar levels.

Alogliptin belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It helps increase insulin release when blood sugar levels are high and reduces excess glucose production after meals.

Metformin belongs to a class of medications called biguanides. It reduces glucose production in the liver and helps the body’s cells respond more effectively to insulin.

Although Kazano can help manage type 2 diabetes, it may cause serious side effects in people with certain medical conditions, particularly kidney disease, liver problems, or heart failure.

Your healthcare provider will assess your medical history, kidney function, blood sugar levels, and other medications before recommending treatment.

Lactic Acidosis

Kazano may rarely cause lactic acidosis, a serious and potentially life-threatening condition in which too much lactic acid builds up in the bloodstream.

Lactic acid is a substance produced naturally when the body uses glucose for energy.

Normally, the liver and kidneys help maintain healthy levels of lactic acid.

However, certain medical conditions or medications can interfere with this process, allowing lactic acid to accumulate.

The metformin component of Kazano is associated with a rare risk of lactic acidosis, particularly when the body cannot eliminate the medication properly.

The risk may increase in people with kidney impairment, significant liver disease, severe dehydration, or conditions that reduce oxygen delivery to body tissues.

Possible symptoms include:

  • Severe Weakness: Feeling unusually tired or lacking energy.
  • Muscle Pain: Unexplained muscle aches or discomfort.
  • Difficulty Breathing: Rapid, deep, or labored breathing.
  • Abdominal Pain: Persistent stomach discomfort, sometimes accompanied by nausea or vomiting.
  • Unusual Drowsiness: Feeling extremely sleepy or less alert than normal.
  • Dizziness: Feeling faint or lightheaded.
  • Slow or Irregular Heartbeat: Changes in heart rhythm that may occur in severe cases.
  • Feeling Unusually Cold: A decrease in body temperature.

Lactic acidosis may develop gradually, and its early symptoms can resemble those of other illnesses.

Stop taking Kazano and seek emergency medical attention immediately if you develop symptoms suggesting lactic acidosis.

Lactic acidosis requires urgent hospital treatment and should not be managed at home.

Your healthcare provider may recommend temporarily stopping Kazano during serious illness, severe dehydration, or other situations that increase the risk of lactic acidosis. 

Kidney Disease and Renal Impairment

Kazano should not be used by people with certain levels of kidney impairment.

The kidneys play an important role in removing both alogliptin and metformin from the body.

Metformin is eliminated largely unchanged through the kidneys.

When kidney function decreases, metformin may accumulate in the bloodstream, increasing the risk of lactic acidosis.

Alogliptin also requires dosage adjustments in people with reduced kidney function.

Because Kazano combines both medications in fixed doses, it may not provide the flexibility needed for patients with kidney disease.

Kidney function is commonly measured using a test called the estimated glomerular filtration rate (eGFR).

According to current U.S. prescribing information, Kazano is not recommended when eGFR is below 60 mL/min/1.73 m², because patients with reduced kidney function may require a lower alogliptin dose than the combination tablet provides.

The medication is contraindicated in patients with severe kidney impairment, defined as an eGFR below 30 mL/min/1.73 m².

Your healthcare provider will check your kidney function before starting Kazano and periodically during treatment.

People with kidney disease may experience symptoms such as:

  • Swelling: Fluid buildup in the ankles, feet, or hands.
  • Changes in Urination: Urinating less frequently or noticing changes in urine output.
  • Fatigue: Persistent tiredness or weakness.
  • Nausea: Ongoing stomach discomfort.
  • Loss of Appetite: Reduced interest in eating.

However, kidney disease may develop without noticeable symptoms, making regular blood tests especially important.

Tell your healthcare provider if you have chronic kidney disease, reduced kidney function, or a history of kidney problems.

Your healthcare provider may recommend another diabetes medication if Kazano is not appropriate for your kidney function. 

Low Blood Sugar (Hypoglycemia)

Kazano may increase the risk of hypoglycemia, particularly when taken with insulin or certain other diabetes medications.

Hypoglycemia occurs when blood sugar falls below the level needed for normal body function.

Alogliptin helps stimulate insulin release in response to elevated blood sugar, while metformin reduces glucose production in the liver.

When Kazano is taken alone, the risk of hypoglycemia is generally low.

However, combining Kazano with insulin or sulfonylureas, such as glimepiride or gliclazide, may increase the risk.

Possible symptoms include:

  • Shakiness: Trembling or feeling unsteady.
  • Sweating: Sudden sweating without physical activity.
  • Increased Hunger: Feeling unusually hungry.
  • Dizziness: Lightheadedness or difficulty maintaining balance.
  • Rapid Heartbeat: A racing or pounding heartbeat.
  • Headache: Pain or pressure in the head.
  • Confusion: Difficulty concentrating or thinking clearly.
  • Weakness: Sudden tiredness or reduced energy.

Severe hypoglycemia may cause seizures, loss of consciousness, or an inability to swallow safely.

If your blood sugar falls below 70 mg/dL (3.9 mmol/L), follow your healthcare provider’s instructions for treating low blood sugar.

For most conscious adults who can swallow safely, treatment involves consuming 15 grams of fast-acting carbohydrates, waiting 15 minutes, and checking blood sugar again.

If blood sugar remains low, repeat the treatment as directed.

Seek emergency medical attention if someone becomes unconscious, experiences a seizure, or cannot swallow safely.

Your healthcare provider may adjust your insulin or sulfonylurea dosage when starting Kazano to reduce the risk of hypoglycemia.

Vitamin B12 Deficiency

Long-term use of metformin, one of the active ingredients in Kazano, may reduce vitamin B12 levels.

Vitamin B12 is an essential nutrient that helps maintain healthy red blood cells, supports nerve function, and contributes to normal DNA production.

Metformin may interfere with vitamin B12 absorption in the digestive system.

Over time, reduced vitamin B12 absorption can lead to a deficiency.

A significant deficiency may cause anemia or neurological symptoms.

Possible signs include:

  • Fatigue: Persistent tiredness or reduced energy.
  • Weakness: Difficulty performing normal activities.
  • Pale Skin: An unusually pale appearance.
  • Tingling or Numbness: Unusual sensations in the hands or feet.
  • Balance Problems: Difficulty walking steadily.
  • Memory or Concentration Problems: Trouble remembering information or focusing.
  • Sore Tongue: Pain, redness, or inflammation of the tongue.

Some symptoms of vitamin B12 deficiency may resemble diabetic neuropathy, a complication of diabetes that affects the nerves.

Tell your healthcare provider if you experience new numbness, tingling, or persistent fatigue while taking Kazano.

Your healthcare provider may recommend periodic vitamin B12 testing, especially if you develop anemia or nerve-related symptoms.

Vitamin B12 deficiency can often be treated with appropriate supplementation when identified.

Do not start high-dose supplements without discussing your needs with your healthcare provider. 

Heart Failure and Cardiovascular Conditions

Kazano should be used with caution in people who have heart failure or are at increased risk of developing it.

Heart failure occurs when the heart cannot pump blood effectively enough to meet the body’s needs.

The alogliptin component of Kazano has been associated with concerns about heart failure in certain patients.

Clinical trials involving alogliptin have reported heart failure events, making it important to consider individual cardiovascular risk before starting treatment.

Metformin may also increase the risk of lactic acidosis in people experiencing acute heart failure or other serious conditions that reduce oxygen delivery to body tissues.

Possible symptoms of heart failure include:

  • Shortness of Breath: Difficulty breathing during physical activity or while resting.
  • Swelling: Fluid buildup in the feet, ankles, or legs.
  • Rapid Weight Gain: Sudden weight increases caused by fluid retention.
  • Persistent Fatigue: Unusual weakness or tiredness.
  • Difficulty Breathing While Lying Down: Needing additional pillows to breathe comfortably.
  • Reduced Exercise Tolerance: Becoming tired or breathless during normal activities.

Tell your healthcare provider if you have a history of heart failure, coronary artery disease, or other significant cardiovascular conditions.

Your healthcare provider will consider the benefits and risks of Kazano and may recommend closer monitoring or an alternative diabetes treatment.

Contact your healthcare provider promptly if you notice new swelling, rapid weight gain, or worsening breathing difficulties.

Seek emergency medical attention if you experience severe shortness of breath, chest pain, or fainting. 

Allergic Reactions and Hypersensitivity

Do not take Kazano if you have experienced a serious allergic reaction to alogliptin, metformin, or any other ingredient in the medication.

Some people may develop allergic reactions, including serious skin reactions or swelling beneath the skin.

Alogliptin has been associated with rare but serious hypersensitivity reactions, including anaphylaxis, angioedema, and Stevens-Johnson syndrome.

Possible symptoms include:

  • Skin Rash: Red or irritated areas of skin.
  • Itching: Persistent skin irritation.
  • Hives: Raised, itchy bumps.
  • Facial Swelling: Swelling around the eyes, lips, or face.
  • Throat Tightness: Difficulty swallowing or breathing.
  • Skin Blisters: Painful blisters or peeling skin that may indicate a serious skin reaction.
  • Mouth Sores: Painful sores involving the mouth or other mucous membranes.

Severe allergic reactions can develop suddenly and require immediate medical attention.

Stop taking Kazano and contact your healthcare provider if you develop signs of an allergic reaction.

Seek emergency medical attention immediately if you experience difficulty breathing, swelling of the tongue or throat, or a widespread blistering skin rash.

Do not restart Kazano after a serious allergic reaction unless your healthcare provider specifically determines that it is safe.

Liver Disease and Hepatic Impairment

Kazano is not recommended for people with significant liver impairment.

The liver helps regulate blood sugar levels and plays an important role in processing lactate.

Although metformin is mainly eliminated through the kidneys rather than being extensively metabolized by the liver, liver disease can interfere with the body’s ability to clear lactate.

This may increase the risk of lactic acidosis.

The alogliptin component has also been associated with reports of serious liver injury, including rare cases of liver failure.

Possible symptoms of liver problems include:

  • Jaundice: Yellowing of the skin or whites of the eyes.
  • Dark Urine: Urine that appears unusually dark.
  • Upper Abdominal Pain: Discomfort on the upper-right side of the abdomen.
  • Nausea: Persistent stomach upset.
  • Loss of Appetite: Reduced desire to eat.
  • Unusual Fatigue: Ongoing tiredness or weakness.
  • Pale Stools: Bowel movements that appear lighter than normal.

Tell your healthcare provider if you have hepatitis, cirrhosis, or a history of abnormal liver function tests.

Your healthcare provider may recommend checking liver function before treatment or when symptoms suggest liver injury.

Stop taking Kazano and seek prompt medical advice if you develop symptoms suggesting serious liver damage.

Your healthcare provider will determine whether another diabetes medication is more appropriate. 

Surgery and Medical Procedures Using Contrast Dye

Tell your healthcare provider if you are scheduled for surgery or a medical imaging procedure while taking Kazano.

Certain procedures may temporarily affect kidney function, hydration, or blood circulation.

These changes can increase the risk of complications involving the metformin component of Kazano.

Surgery

Patients undergoing major surgery may need to temporarily stop Kazano.

Surgery can sometimes involve fasting, changes in fluid intake, dehydration, or temporary changes in blood pressure.

These factors may increase the risk of lactic acidosis in susceptible individuals.

Your healthcare provider will explain when to stop taking Kazano and when it is safe to restart treatment.

Do not discontinue Kazano before a minor procedure unless instructed.

Imaging Procedures Using Iodinated Contrast

Some imaging procedures, including certain CT scans and angiograms, use iodinated contrast dye to make internal structures easier to see.

In some patients, iodinated contrast can cause an acute decline in kidney function.

Reduced kidney function may lead to metformin accumulation and increase the risk of lactic acidosis.

Kazano may need to be stopped at or before contrast administration, depending on your kidney function, medical history, and the type of procedure.

For patients who require interruption, kidney function is generally reassessed approximately 48 hours after the procedure before Kazano is restarted.

Not every imaging procedure requires Kazano to be stopped. Your healthcare provider will determine whether temporary interruption is necessary.

Always inform the healthcare team performing your procedure that you take Kazano. 

Pregnancy and Breastfeeding

Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before taking Kazano.

Blood sugar control is especially important during pregnancy because uncontrolled diabetes can increase the risk of complications for both the pregnant person and the developing baby.

However, the safety of the alogliptin and metformin combination during pregnancy has not been adequately established.

There is limited information about the effects of alogliptin during human pregnancy.

Metformin has been studied more extensively, and available research has not shown a clear increase in major birth defects. However, this does not establish the safety of the fixed combination product.

Your healthcare provider may recommend a different diabetes treatment during pregnancy, depending on your condition and blood sugar levels.

Breastfeeding

It is not known whether alogliptin passes into human breast milk.

Metformin passes into breast milk in small amounts, but information about the combined effects of alogliptin and metformin on breastfed infants is limited.

Your healthcare provider will consider your need for diabetes treatment, the benefits of breastfeeding, and any potential risks to your baby.

Do not start or continue Kazano during pregnancy or breastfeeding without medical advice.

If you become pregnant while taking Kazano, contact your healthcare provider promptly to review your treatment plan.

Use in Older Adults

Older adults may be more sensitive to certain side effects of Kazano, particularly those associated with reduced kidney function.

Kidney function often decreases with age, which can affect how efficiently metformin and alogliptin are eliminated from the body.

When kidney function is significantly reduced, metformin may accumulate and increase the risk of lactic acidosis.

Older adults may also have additional medical conditions, including heart disease, liver problems, or dehydration, that affect treatment safety.

Your healthcare provider may recommend:

  • Kidney Function Monitoring: More frequent blood tests to assess kidney health.
  • Blood Sugar Monitoring: Regular glucose testing to evaluate treatment effectiveness.
  • Medication Reviews: Checking for interactions with other prescription medications.
  • Hydration Monitoring: Ensuring adequate fluid intake when appropriate.
  • Dosage Assessment: Reviewing whether the prescribed dosage remains suitable.

Tell your healthcare provider if you experience persistent weakness, dizziness, dehydration, or unusual changes in your blood sugar readings.

Do not adjust your Kazano dosage without medical advice.

Other Important Precautions

Kazano may also cause other serious side effects that require medical attention.

Pancreatitis

Alogliptin has been associated with acute pancreatitis, an inflammation of the pancreas.

Symptoms may include severe, persistent abdominal pain that sometimes spreads to the back, with or without vomiting.

Stop taking Kazano and seek immediate medical evaluation if you develop symptoms suggesting pancreatitis.

Severe Joint Pain

DPP-4 inhibitors, including alogliptin, have been associated with severe and sometimes disabling joint pain.

Tell your healthcare provider if you develop significant joint pain after starting Kazano.

Bullous Pemphigoid

Bullous pemphigoid is a rare skin condition that causes large, fluid-filled blisters.

Cases have been reported in patients taking DPP-4 inhibitors.

Contact your healthcare provider promptly if you develop unexplained skin blisters or sores. 

When to Contact Your Healthcare Provider

Contact your healthcare provider if you experience persistent nausea, unusual fatigue, frequent low blood sugar readings, swelling, worsening digestive symptoms, or changes in your urination.

Tell your healthcare provider if you develop kidney problems, liver disease, or heart failure, or if you are scheduled for surgery or a contrast imaging procedure.

Seek prompt medical attention if you experience persistent abdominal pain, unexplained skin blisters, or symptoms suggesting liver injury.

Seek emergency medical attention if you develop severe breathing difficulties, unusual drowsiness with profound weakness, loss of consciousness, or symptoms suggesting lactic acidosis.

Kazano can help manage type 2 diabetes, but safe treatment requires regular monitoring of kidney function, blood sugar levels, and possible side effects. Following your prescribed dosage, attending medical appointments, and reporting unusual symptoms can help reduce the risk of serious complications.

How Often Should Kazano Be Taken?

Kazano is usually taken twice daily with meals, once in the morning and once in the evening. Kazano is a prescription medication used to help control blood sugar levels in adults with type 2 diabetes mellitus. It combines two active ingredients that work together to reduce elevated blood sugar levels. Alogliptin helps the pancreas release insulin when blood sugar levels are high, while metformin reduces glucose production in the liver and improves the body’s response to insulin. The usual adult dosing schedule is one tablet twice daily. However, the tablet strength depends on your current diabetes treatment, kidney function, and response to the medication. Kazano is available in different strengths, including 12.5 mg/500 mg and 12.5 mg/1000 mg. Your healthcare provider will determine the appropriate strength based on your medical needs. Taking Kazano at approximately the same times each day helps maintain a consistent treatment routine. Do not take more than two doses daily or increase your prescribed tablet strength without medical advice. Continue following your recommended diet, exercise routine, and blood sugar monitoring schedule while taking Kazano.

Can Kazano Be Taken on an Empty Stomach?

Kazano should be taken with meals rather than on an empty stomach. One of its active ingredients, metformin, can cause gastrointestinal side effects, particularly when treatment begins or the dosage is increased. Common digestive side effects include nausea, diarrhea, stomach discomfort, bloating, and loss of appetite. Taking Kazano with food helps reduce these symptoms and may make the medication easier to tolerate. For example, if your healthcare provider prescribes Kazano twice daily, you may take one tablet with breakfast and another with your evening meal. Swallow the tablet whole with a glass of water. Do not crush, split, or chew the tablet. If you experience persistent nausea, diarrhea, or abdominal discomfort despite taking Kazano with food, contact your healthcare provider. Your healthcare provider may adjust your treatment or recommend another approach to managing these side effects. Taking Kazano with meals helps improve gastrointestinal tolerability while supporting consistent blood sugar control.

Is Kazano Safe for Use in Elderly Patients?

Kazano may be prescribed to older adults with type 2 diabetes, but additional precautions are necessary because kidney function often decreases with age. Both alogliptin and metformin are eliminated from the body partly or mainly through the kidneys. When kidney function becomes impaired, these medications may accumulate in the bloodstream and increase the risk of side effects. Metformin is associated with a rare but serious condition called lactic acidosis, which occurs when excessive lactic acid builds up in the bloodstream. Older adults with reduced kidney function, dehydration, heart failure, or other significant medical conditions may have a higher risk of developing this complication. Your healthcare provider will assess your kidney function before prescribing Kazano and monitor it periodically during treatment. The medication may not be appropriate for older adults with certain levels of kidney impairment. Older adults may also take several prescription medications, increasing the possibility of drug interactions. For these reasons, your healthcare provider may recommend regular blood sugar monitoring, kidney function tests, and medication reviews. Age alone does not automatically prevent someone from using Kazano. However, treatment should be based on individual health needs rather than age alone. Contact your healthcare provider if you experience persistent weakness, severe nausea, dizziness, dehydration, or unusual changes in blood sugar levels.

Can Kazano Cause Weight Gain?

Kazano is generally considered a weight-neutral diabetes medication, meaning it does not usually cause significant weight gain. Kazano contains alogliptin, a DPP-4 inhibitor, and metformin, a biguanide. These medications help improve blood sugar control without directly promoting substantial weight gain. Alogliptin typically has little effect on body weight. Metformin may cause modest weight loss in some people, although this effect varies between individuals. Metformin helps reduce glucose production in the liver and improves insulin sensitivity. Some people may also experience changes in appetite during treatment. However, Kazano is not approved as a weight-loss medication and should not be used specifically to lose weight. Changes in body weight while taking Kazano may depend on several factors, including diet, physical activity, other diabetes medications, and overall health. For example, medications such as insulin and certain sulfonylureas may cause weight gain when used alongside other diabetes treatments. If you experience sudden or unexplained weight gain, especially with swelling in your ankles, feet, or legs, contact your healthcare provider. Rapid weight gain accompanied by swelling or shortness of breath may indicate fluid retention or a heart-related problem rather than an increase in body fat. Maintaining a balanced diet and regular physical activity can help support healthy weight management while taking Kazano.

How Long Does It Take for Kazano to Start Working?

Kazano begins affecting blood sugar regulation after treatment starts, but the time needed to notice improvements varies from person to person. Some people may notice lower blood sugar readings within the first few days of treatment. However, it may take several weeks for your healthcare provider to evaluate how well the medication is controlling your blood sugar levels. Kazano works through two complementary mechanisms. Alogliptin increases the activity of incretin hormones, which help regulate insulin release and reduce excess glucose production after meals. Metformin decreases glucose production in the liver and improves the body’s response to insulin. Together, these actions help reduce both fasting and after-meal blood sugar levels. Your healthcare provider may recommend checking your blood sugar regularly to monitor your response. An HbA1c test is also commonly used to evaluate long-term blood sugar control. HbA1c measures your average blood sugar levels over approximately two to three months. For this reason, the full effect of Kazano on HbA1c is usually assessed after about three months of treatment. If your blood sugar readings remain consistently above or below your recommended range, contact your healthcare provider. Your treatment plan may need adjustment based on your glucose results, kidney function, diet, physical activity, and other medications. Do not increase your Kazano dosage or stop taking it without consulting your healthcare provider.

REVIEWS

Additional Information Book
Generic name:

metformin hydrochloride/alogliptin benzoate

Formulation:

Tablet

Strength(s):

12.5mg/1000mg

Quantities Available:

56, 112

Why customers love Online Pharmacies Canada

Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.

Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.

How to Order

How much Kazano can I order at once from a Canadian pharmacy?

When ordering Kazano (metformin hydrochloride/alogliptin benzoate) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.

Here’s what you need to know:

Dosage and Quantity: Kazano is commonly prescribed in dosages of 12.5 mg/1000 mg, taken twice daily. For a 90-day supply, this means you would order 180 tablets (90 days x 2 tablets per day).

Do you sell metformin hydrochloride/alogliptin benzoate?

No, we do not sell metformin hydrochloride/alogliptin benzoate directly on our website. However, you can still enjoy low prices on Kazano, which contains metformin hydrochloride/alogliptin benzoate as an active ingredient. To purchase Kazano, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.

Do you offer shipping of Kazano (metformin hydrochloride/alogliptin benzoate) to the United States?

Yes, we ship Kazano (metformin hydrochloride/alogliptin benzoate) to both the United States and Puerto Rico.

Discover Our Users' Stories!

Watch how Online Pharmacies Canada is helping customers save money on their medications.

Online Pharmacies Canada Customer Testimonial #4
Online Pharmacies Canada Customer Testimonial #1
Online Pharmacies Canada - Customer Testimonial #2

Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Kazano (metformin hydrochloride/alogliptin benzoate). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Kazano (metformin hydrochloride/alogliptin benzoate).